Case Study: Biosceptre.

Sign up to receive the latest insights, news, event announcements and more from PEM

Sign up

Kreston Global and PEM advise biopharmaceutical company BiosceptreBiosceptre is a leading biopharmaceutical company focused on providing new therapies for a wide range of cancer patients. Its researchers work on cell-therapy and immune-oncology treatment and have made significant discoveries to help target cancer cells more effectively.

Using the Kreston Global network, PEM recommended firms based in Australia and the UAE to provide tax advice and audit services to Biosceptre’s subsidiary companies.

To read this case study in full, please click the button below.

Download the full case study